Back to Search
Start Over
Current Trends in Organ Preservation Solutions for Pancreas Transplantation: A Single-Center Retrospective Study.
- Source :
-
Transplant international : official journal of the European Society for Organ Transplantation [Transpl Int] 2022 Mar 28; Vol. 35, pp. 10419. Date of Electronic Publication: 2022 Mar 28 (Print Publication: 2022). - Publication Year :
- 2022
-
Abstract
- Due to the high vulnerability of the pancreas to ischemia-reperfusion injury, choices regarding preservation solution markedly affect pancreas transplant success. A retrospective single-center analysis of 380 pancreas transplants (2000-2019) was performed to correlate current preservation solutions with transplant outcomes. Early graft failure requiring transplantectomy within 30 days post-transplant occurred in 7.5% for University of Wisconsin (UW) group ( n = 267), 10.8% of Celsior (CS) group ( n = 83), 28.5% of Histidine-Tryptophan-Ketoglutarate (HTK) group ( n = 7), and none for Institut Georges Lopez-1 (IGL-1) group ( n = 23). The most common causes of technical failures in this cohort included abdominal hemorrhage (8.4%); graft pancreatitis (3.7%); fluid collections (2.6%); intestinal complications (6.6%); and vascular thrombosis (20.5%). Although IGL-1 solution provided lower surgical complication rates, no significant differences were found between studied groups. Nevertheless, HTK solution was associated with elevated pancreatitis rates. The best graft survival was achieved at 1 year using UW and IGL-1, and at 3 and 5 years using IGL-1 ( p = 0.017). There were no significant differences in patient survival after a median follow-up of 118.4 months. In this setting therefore, IGL-1 solution appears promising for perfusion and organ preservation in clinical pancreas transplantation, compared to other commonly used solutions.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2022 Ferrer-Fàbrega, Folch-Puy, Lozano, Ventura-Aguiar, Cárdenas, Paredes, García-Criado, Bombí, García-Pérez, López-Boado, Rull, Esmatjes, Ricart, Diekmann, Fondevila, Fernández-Cruz, Fuster and García-Valdecasas.)
Details
- Language :
- English
- ISSN :
- 1432-2277
- Volume :
- 35
- Database :
- MEDLINE
- Journal :
- Transplant international : official journal of the European Society for Organ Transplantation
- Publication Type :
- Academic Journal
- Accession number :
- 35418805
- Full Text :
- https://doi.org/10.3389/ti.2022.10419